Intracerebral Delivery of Brain-Derived Neurotrophic Factor Using HyStem®-C Hydrogel Implants Improves Functional Recovery and Reduces Neuroinflammation in a Rat Model of Ischemic Stroke
Autor: | Rachel K. Lam, Sezen Kislal, Denise I. Briggs, Thomas I. Zarembinski, Tiffany Nguyen, Mehrdad Shamloo, Kristine Ravina, Zuha Warraich |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
functional recovery Infarction Striatum Pharmacology Catalysis neuroinflammation Inorganic Chemistry lcsh:Chemistry 03 medical and health sciences 0302 clinical medicine Neurotrophic factors ischemic stroke Medicine Physical and Theoretical Chemistry Molecular Biology lcsh:QH301-705.5 Spectroscopy Neuroinflammation Brain-derived neurotrophic factor business.industry Organic Chemistry brain-derived neurotrophic factor General Medicine medicine.disease Computer Science Applications 030104 developmental biology medicine.anatomical_structure lcsh:Biology (General) lcsh:QD1-999 Self-healing hydrogels Implant hydrogel business 030217 neurology & neurosurgery Astrocyte |
Zdroj: | International Journal of Molecular Sciences, Vol 19, Iss 12, p 3782 (2018) International Journal of Molecular Sciences Volume 19 Issue 12 |
ISSN: | 1422-0067 |
Popis: | Ischemic stroke is a leading cause of death and disability worldwide. Potential therapeutics aimed at neural repair and functional recovery are limited in their blood-brain barrier permeability and may exert systemic or off-target effects. We examined the effects of brain-derived neurotrophic factor (BDNF), delivered via an extended release HyStem® C hydrogel implant or vehicle, on sensorimotor function, infarct volume, and neuroinflammation, following permanent distal middle cerebral artery occlusion (dMCAo) in rats. Eight days following dMCAo or sham surgery, treatments were implanted directly into the infarction site. Rats received either vehicle, BDNF-only (0.167 µ g/µ L), hydrogel-only, hydrogel impregnated with 0.057 µ L of BDNF (hydrogel + BDNFLOW), or hydrogel impregnated with 0.167 µ L of BDNF (hydrogel + BDNFHIGH). The adhesive removal test (ART) and 28-point Neuroscore (28-PN) were used to evaluate sensorimotor function up to two months post-ischemia. The hydrogel + BDNFHIGH group showed significant improvements on the ART six to eight weeks following treatment and their behavioral performance was consistently greater on the 28-PN. Infarct volume was reduced in rats treated with hydrogel + BDNFHIGH as were levels of microglial, phagocyte, and astrocyte marker immunoexpression in the corpus striatum. These data suggest that targeted intracerebral delivery of BDNF using hydrogels may mitigate ischemic brain injury and restore functional deficits by reducing neuroinflammation. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |